Summit Partners has completed a growth investment in RIS Rx, according to a news release.

RIS Rx, founded in 2020 and based in Newport Beach, California, is a healthcare technology company that develops solutions designed to address revenue leakage in pharma.

Summit, founded in 1994 and based in Boston, pursues opportunities in healthcare services, healthcare technology and life sciences as well as in other growth sectors. The firm targets growth equity and fixed income investments of $10 million to more than $500 million per company. 

Terms of the investment were not disclosed.